
AAB Therapeutics develops precision biological drugs to treat cancer and autoimmune diseases without the systemic side-effects of chemotherapy. We are establishing a genetically programmable precision drug delivery platform that produces engineered extracellular vesicles (EVs). These nano-vesicles are decorated with antibodies to target them to specific cells and loaded with RNA drugs that kill the cancer cells. We use a proprietary AI model to choose the optimal combination of targeting antibodies. This modular platform can be rapidly re-targeted to other diseases by changing only a few…
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.